Literature DB >> 24108608

Temporal and spatial compartmentalization of drug-resistant cytomegalovirus (CMV) in a child with CMV meningoencephalitis: implications for sampling in molecular diagnosis.

Pierre Frange1, David Boutolleau, Marianne Leruez-Ville, Fabien Touzot, Guilhem Cros, Sebastien Heritier, Despina Moshous, Benedicte Neven, Alain Fischer, Stephane Blanche.   

Abstract

We describe a case of antiviral-resistant cytomegalovirus meningoencephalitis occurring after hematopoietic stem cell transplantation. Antiviral-resistant cytomegalovirus was identified in blood 16 months earlier. However, wild-type cytomegalovirus was evidenced in blood when the meningoencephalitis was diagnosed. Treatment of meningoencephalitis should be adapted to all previously identified resistance mutations in any compartment.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24108608      PMCID： PMC3838023          DOI： 10.1128/JCM.02411-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency.

Authors:  Samuel C Blackman; Nell S Lurain; David P Witte; Alexandra H Filipovich; Pam Groen; Mark R Schleiss
Journal:  J Pediatr Hematol Oncol       Date:  2004-09       Impact factor: 1.289

2.  Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein.

Authors:  D Michel; S Höhn; T Haller; D Jun; T Mertens
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

Review 3.  CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency.

Authors:  S M Reddy; D J Winston; M C Territo; G J Schiller
Journal:  Bone Marrow Transplant       Date:  2010-03-01       Impact factor: 5.483

4.  Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation.

Authors:  M Battiwalla; P Paplham; N G Almyroudis; A McCarthy; A Abdelhalim; A Elefante; P Smith; J Becker; P L McCarthy; B H Segal
Journal:  Transpl Infect Dis       Date:  2007-03       Impact factor: 2.228

5.  Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis.

Authors:  A Erice; N Borrell; W Li; W J Miller; H H Balfour
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

6.  Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.

Authors:  S Alain; S Hantz; C Scieux; A Karras; M C Mazeron; J C Szelag; B M Imbert; A M Fillet; S Gouarin; C Mengelle; A De Wilde; N Cogne; G Champier; S Rogez; C Legendre; F Denis
Journal:  J Med Virol       Date:  2004-08       Impact factor: 2.327

7.  Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation.

Authors:  R Zeiser; C Grüllich; H Bertz; G Pantazis; F T Hufert; T A Bley; J Finke
Journal:  Bone Marrow Transplant       Date:  2004-01       Impact factor: 5.483

8.  Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients.

Authors:  Dana G Wolf; Nell S Lurain; Tsila Zuckerman; Ron Hoffman; Judith Satinger; Alik Honigman; Niveen Saleh; Emanuel S Robert; Jacob M Rowe; Zipora Kra-Oz
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

9.  Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet.

Authors:  Petr Hubacek; Petra Keslova; Renata Formankova; Pavel Pochop; Ondrej Cinek; Miroslav Zajac; Jana Lochmanova; Jan Stary; Petr Sedlacek
Journal:  Pediatr Transplant       Date:  2008-11-01

10.  Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection.

Authors:  David Boutolleau; Claire Deback; Céline Bressollette-Bodin; Shaida Varnous; Nathalie Dhedin; Benoît Barrou; Jean-Paul Vernant; Iradj Gandjbakhch; Berthe-Marie Imbert-Marcille; Henri Agut
Journal:  Antiviral Res       Date:  2008-12-06       Impact factor: 5.970
View more
  7 in total

Review 1.  Human cytomegalovirus intrahost evolution-a new avenue for understanding and controlling herpesvirus infections.

Authors:  Nicholas Renzette; Laura Gibson; Jeffrey D Jensen; Timothy F Kowalik
Journal:  Curr Opin Virol       Date:  2014-08-25       Impact factor: 7.090

2.  Limits and patterns of cytomegalovirus genomic diversity in humans.

Authors:  Nicholas Renzette; Cornelia Pokalyuk; Laura Gibson; Bornali Bhattacharjee; Mark R Schleiss; Klaus Hamprecht; Aparecida Y Yamamoto; Marisa M Mussi-Pinhata; William J Britt; Jeffrey D Jensen; Timothy F Kowalik
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

3.  Compartmentalization of a Multidrug-Resistant Cytomegalovirus UL54 Mutant in a Stem Cell Transplant Recipient with Encephalitis.

Authors:  Jocelyne Piret; Manuel Schibler; Van Dung Pham; Sébastien Hantz; Federica Giannotti; Stavroula Masouridi-Levrat; Laurent Kaiser; Nathalie Goyette; Sophie Alain; Rong Shi; Guy Boivin
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

4.  On the relative roles of background selection and genetic hitchhiking in shaping human cytomegalovirus genetic diversity.

Authors:  Nicholas Renzette; Timothy F Kowalik; Jeffrey D Jensen
Journal:  Mol Ecol       Date:  2015-09-03       Impact factor: 6.185

5.  Pathological Methods Applied to the Investigation of Causes of Death in Developing Countries: Minimally Invasive Autopsy Approach.

Authors:  Paola Castillo; Esperança Ussene; Mamudo R Ismail; Dercio Jordao; Lucilia Lovane; Carla Carrilho; Cesaltina Lorenzoni; Marcus V Lacerda; Antonio Palhares; Leonardo Rodríguez-Carunchio; Miguel J Martínez; Jordi Vila; Quique Bassat; Clara Menéndez; Jaume Ordi
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

6.  Clinical utility of bronchoalveolar lavage cytomegalovirus viral loads in the diagnosis of cytomegalovirus pneumonitis in infants.

Authors:  Kerusha Govender; Prakash Jeena; Raveen Parboosing
Journal:  J Med Virol       Date:  2016-12-05       Impact factor: 2.327

7.  Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection.

Authors:  G Clement Dobbins; Amit Patki; Dongquan Chen; Hemant K Tiwari; Curtis Hendrickson; William J Britt; Karen Fowler; Jake Y Chen; Suresh B Boppana; Shannon A Ross
Journal:  BMC Infect Dis       Date:  2019-12-10       Impact factor: 3.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.